MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal- like breast cancer
M. Milevskiy, G. Sandhu, A. Wronski, D. Korbie, B. Brewster, A. Shewan, S. Edwards, J. French, M. Brown
The paper identifies miR-29b-1-5p as a biomarker in basal-like breast cancer, showing its prognostic significance in BRCA1-deficient tumors.
bioRxiv · May 10, 2018Cancer Biology